SCHEMBL29360239

SCHEMBL29360239

N=C1NC2CC=CC=C2S1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL709998 0.77
SCHEMBL9429297 0.77
SCHEMBL8089696 0.70
SCHEMBL18890497 0.69 MEN1 (0.40)
SCHEMBL7581735 0.69 MEN1 (0.40)
Hydrochloric Acid SCHEMBL11685389 0.68 MEN1 (0.39)
SCHEMBL917042 0.65
SCHEMBL4931900 0.65 MEN1 (0.36)
SCHEMBL4057592 0.64
SCHEMBL209505 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220023450-A1 BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-01-27 US disclosed